Following up on this work in vivo using mice with Huntington's disease phenotype, the researchers also observed that these changes in methylation status were associated with improved motor function and cognition in mice treated with an HDAC inhibitor compared to mice treated with a vehicle control [96]. Here, HDAC9 is linked to Huntington disease.